← FDA Drug Approvals (Drugs@FDA)

SEREVENT

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1994-02-04

Drug application

FDA Application #

NDA020236

Application type

New Drug Application

Brand name

SEREVENT

Generic name

Salmeterol Xinafoate

Active ingredients

SALMETEROL XINAFOATE

Dosage form

AEROSOL, METERED

Route

INHALATION

Marketing status

Discontinued

Sponsor

GLAXOSMITHKLINE

First approval

1994-02-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown